DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today announces that it will be presenting brand-new data on ...
In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...
Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the EZ2 DNA Investigator Sep&Prep Kit, ...
Pillar Biosciences, Inc., the leader in Decision Medicine(TM), announced its participation in the 2025 Association for Molecular Pathology (AMP) Annual Meeting in Boston, MA. The company and ...
ETH Zurich scientists have created “MetaGraph,” a revolutionary DNA search engine that functions like Google for genetic data. By compressing global genomic datasets by a factor of 300, it allows ...
Pharmacists are integral to oncology care, optimizing treatment plans, managing adverse effects, and supporting precision medicine through collaborative practice agreements.
In modern retail logistics, where distribution centers support omnichannel fulfillment strategies, the complexity of outbound ...
Biomarker testing helps identify effective targeted therapies and avoid those that are less likely to work in certain ...
In this interview, we explore how single-cell technologies, automation and strategic partnerships are shaping the future of cancer immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback